The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Katunina E.A.

Federal Center of Brain and Neurotechnologies;
Pirogov Russian National Research Medical University

Shipilova N.N.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Katunin D.A.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches

Authors:

Katunina E.A., Shipilova N.N., Katunin D.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8): 21‑26

DOI: 10.17116/jnevro202212208121

Read: 3151 times

Download PDF (RU)
Contact the author
Table of contents

MECHANISMS OF DEVELOPMENT OF CONSTIPATION IN PARKINSON’S DISEASE AND THERAPEUTIC APPROACHES
MECHANISMS OF DEVELOPMENT OF CONSTIPATION IN PARKINSON’S DISEASE AND THERAPEUTIC APPROACHES

To cite this article:

Katunina EA, Shipilova NN, Katunin DA. Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8):21‑26. (In Russ.)
https://doi.org/10.17116/jnevro202212208121

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Comparative analysis of the resu­lts of treatment of gastric polyps by methods of loop electroexcision, laser and endo­scopic poly­pectomy with aspi­ration capture. Endo­scopic Surgery. 2024;(6):24-30
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Abstract:

Constipation is one of the most common non-motor symptoms of Parkinson’s disease. The pathogenetic mechanisms of constipation, diagnostic criteria, approaches to investigations and treatment are discussed in the paper.

Keywords:

Parkinson’s disease
constipation
pathogenesis
treatment

Authors:

Katunina E.A.

Federal Center of Brain and Neurotechnologies;
Pirogov Russian National Research Medical University

Shipilova N.N.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Katunin D.A.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Received:

09.03.2022

Accepted:

15.03.2022

Close metadata

References:

  1. Balestrino R, Martinez-Martin P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. Journal of the Neurological Sciences. 2017;373:173-178.  https://doi.org/10.1016/j.jns.2016.12.060
  2. Sharma A, Kurek J, Morgan J, Wakade C, Rao S. Constipation in Parkinson’s Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle? Curr Gastroenterol Rep. 2018;20(1):1.  https://doi.org/10.1007/s11894-018-0609-x
  3. Stirpe P, Hoffman M, Badiali D, Colosimo C. Constipation: an emerging risk factor for Parkinson’s disease? Eur J Neurol. 2016;23:1606-1613. https://doi.org/10.1111/ene.13082
  4. Fasano A, Visanji N, Liu L, et al. Gastrointestinal dysfunction in Parkinson’s disease. The Lancet Neurology. 2015;14:625-639.  https://doi.org/10.1016/s1474-4422(15)00007-1
  5. Chen H, Zhao E, Zhang W, et al. Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015;4(1):1.  https://doi.org/10.1186/2047-9158-4-1
  6. Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectoanal videomanometry in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74:268-272.  https://doi.org/10.1136/jnnp.74.2.268
  7. Longstreth G, Thompson W, Chey W, et al. Functional Bowel Disorders. Gastroenterology. 2006;130(5):1480-1491. https://doi.org/10.1053/j.gastro.2005.11.061
  8. Cersosimo M, Raina G, Pecci C, et al. Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms. J Neurol. 2012;260:1332-1338. https://doi.org/10.1007/s00415-012-6801-2
  9. Edwards L, Pfeiffer R, Quigley E, et al. Gastrointestinal symptoms in Parkinson’s disease. Movement Disorders. 1991;6:151-156.  https://doi.org/10.1002/mds.870060211
  10. Chaudhuri K, Martinez-Martin P, Schapira A, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: The NMSQuest study. Movement Disorders. 2006;21:916-923.  https://doi.org/10.1002/mds.20844
  11. Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol. 1990;53:463-468. 
  12. Lin C, Lin J, Liu Y, et al. Risk of Parkinson’s disease following severe constipation: A nationwide population-based cohort study. Parkinsonism Relat Disord. 2014;20(12):1371-1375. https://doi.org/10.1016/j.parkreldis.2014.09.026
  13. Sung H, Park J, Kim J. The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease. J Mov Disord. 2014;7(1):7-12.  https://doi.org/10.14802/jmd.14002
  14. Picillo M, Amboni M, Erro R, et al. Gender differences in non-motor symptoms in early, drug naïve Parkinson’s disease. J Neurol. 2013;260(11):2849-2855. https://doi.org/10.1007/s00415-013-7085-x
  15. Kim H, Park S, Cho Y, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci. 2009;287(1-2):200-204.  https://doi.org/10.1016/j.jns.2009.07.026
  16. Pont-Sunyer C, Hotter A, Gaig C, et al. The Onset of Nonmotor Symptoms in Parkinson’s disease (The ONSET PDStudy). Movement Disorders. 2015;30(2):229-237.  https://doi.org/10.1002/mds.26077
  17. Krogh K, Ostergaard K, Sabroe S, Laurberg S. Clinical aspects of bowel symptoms in Parkinson’s disease. Acta Neurol Scand. 2008;117:60-64.  https://doi.org/10.1111/j.1600-0404.2007.00900.x
  18. Visser M, Marinus J, Stiggelbout A, Van Hilten J. Assessment of autonomic dysfunction in Parkinson’s disease: The SCOPA-AUT. Movement Disorders. 2004;19:1306-1312. https://doi.org/10.1002/mds.20153
  19. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20:99-105.  https://doi.org/10.1016/j.parkreldis.2013.09.025
  20. Sakakibara R, Shinotoh H, Uchiyama T et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Autonomic Neuroscience. 2001;92:76-85.  https://doi.org/10.1016/s1566-0702(01)00295-8
  21. Zibetti M, Torre E, Cinquepalmi A, et al. Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus. Eur Neurol. 2007;58:218-223.  https://doi.org/10.1159/000107943
  22. Gaenslen A, Swid I, Liepelt-Scarfone I, et al. The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Movement Disorders. 2011;26:653-658.  https://doi.org/10.1002/mds.23499
  23. Santos-García D, de la Fuente-Fernández R. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease. J Neurol Sci. 2013;332:136-140.  https://doi.org/10.1016/j.jns.2013.07.005
  24. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Movement Disorders. 2009;24:1641-1649. https://doi.org/10.1002/mds.22643
  25. Edwards L, Quigley E, Hofman R, Pfeiffer R. Gastrointestinal symptoms in parkinson disease: 18-month follow-up study. Movement Disorders. 1993;8:83-86.  https://doi.org/10.1002/mds.870080115
  26. Neikrug A, Avanzino J, Liu L, et al. Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med. 2014;15:959-966.  https://doi.org/10.1016/j.sleep.2014.04.009
  27. Giorelli M, Bagnoli J, Consiglio L, et al. Change in non-motor symptoms in Parkinson’s disease and essential tremor patients: a one-year follow-up study. Tremor Other Hyperkinet Mov (N Y). 2014;4:216.  https://doi.org/10.7916/D82J68TH
  28. Spica V, Pekmezović T, Svetel M, Kostić V. Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson’s disease. J Neurol. 2013;260:131-137.  https://doi.org/10.1007/s00415-012-6600-9
  29. Khoo T, Yarnall A, Duncan G, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80:276-281.  https://doi.org/10.1212/wnl.0b013e31827deb74
  30. Khedr E, El Fetoh N, Khalifa H, et al. Prevalence of non motor features in a cohort of Parkinson’s disease patients. Clin Neurol Neurosurg. 2013;115:673-677.  https://doi.org/10.1016/j.clineuro.2012.07.032
  31. Crosiers D, Pickut B, Theuns J, et al. Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson’s disease patients as assessed by the Non-Motor Symptoms Questionnaire. Am J Neurodegener Dis. 2012;1:160-167. 
  32. Martinez-Martin P, Schapira A, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders. 2007;22:1623-1629. https://doi.org/10.1002/mds.21586
  33. Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69:333-341.  https://doi.org/10.1212/01.wnl.0000266593.50534.e8
  34. Siddiqui M, Rast S, Lynn M, et al. Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8:277-284.  https://doi.org/10.1016/s1353-8020(01)00052-9
  35. Yu B, Xiao ZY, Li JZ, et al. Study of an integrated non-motor symptoms questionnaire for Parkinson’s disease. Chin Med J. 2010;123:1436-1440.
  36. Rodríguez-Violante M, de Saráchaga A, Cervantes-Arriaga A, et al. Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson’s Disease: A Retrospective Study. J Parkinsons Dis. 2016;6:183-190.  https://doi.org/10.3233/jpd-150705
  37. Postuma R, Adler C, Dugger B, et al. REM sleep behavior disorder and neuropathology in Parkinson’s disease. Movement Disorders. 2015;30:1413-1417. https://doi.org/10.1002/mds.26347
  38. Fereshtehnejad S, Romenets S, Anang J, et al. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression. JAMA Neurol. 2015;72:863.  https://doi.org/10.1001/jamaneurol.2015.0703
  39. Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:252-255.  https://doi.org/10.1016/j.parkreldis.2009.12.010
  40. Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J Neurol. 2012;259:1639-1647. https://doi.org/10.1007/s00415-011-6392-3
  41. Forjaz M, Ayala A, Rodriguez-Blazquez C, Frades-Payo B, Martinez-Martin P. Assessing autonomic symptoms of Parkinson’s disease with the SCOPA-AUT: a new perspective from Rasch analysis. Eur J Neurol. 2010;17(2):273-279.  https://doi.org/10.1111/j.1468-1331.2009.02835.x
  42. Chaudhuri K, Martinez-Martin P, Brown R, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Movement Disorders. 2007;22(13):1901-1911. https://doi.org/10.1002/mds.21596
  43. Edwards L, Quigley E, Harned R, Hofman R, Pfeiffer R. Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol. 1994;89:15-25. 
  44. Jost W, Schrank B. Defecatory disorders in de novo Parkinsonians—colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr. 1998;110(15):535-537. 
  45. Cersosimo M, Benarroch E. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Movement Disorders. 2008;23(8):1065-1075. https://doi.org/10.1002/mds.22051
  46. Jost W, Schimrigk K. Constipation in Parkinson’s disease. Klin Wochenschr. 1991;69:906-909.  https://doi.org/10.1007/bf01798536
  47. Ashraf W, Pfeiffer R, Park F, et al. Constipation in parkinson’s disease: Objective assessment and response to psyllium. Movement Disorders. 1997;12(6):946-951.  https://doi.org/10.1002/mds.870120617
  48. Shannon K, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Movement Disorders. 2012;6:709-715.  https://doi.org/10.1002/mds.23838
  49. Visanji N, Brooks P, Hazrati L, Lang A. The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathol Commun. 2013;1:2.  https://doi.org/10.1186/2051-5960-1-2
  50. Beach T, Adler C, Sue L, et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2009;119:689-702.  https://doi.org/10.1007/s00401-010-0664-3
  51. Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol. 2002;249(3):1-5.  https://doi.org/10.1007/s00415-002-1301-4
  52. Gai W, Blumbergs P, Geffen L, Blessing W. Age-related loss of dorsal vagal neurons in Parkinson’s disease. Neurology. 1992;42:2106-2111. https://doi.org/10.1212/wnl.42.11.2106
  53. Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors. Nature Reviews Neurology. 2015;11(11):625-636.  https://doi.org/10.1038/nrneurol.2015.197
  54. Pan-Montojo F, Schwarz M, Winkler C, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898.  https://doi.org/10.1038/srep00898
  55. Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805-820.  https://doi.org/10.1007/s00401-014-1343-6
  56. Svensson E, Horváth-Puhó E, Thomsen R, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78:522-529.  https://doi.org/10.1002/ana.24448
  57. Braak H, Sastre M, Bohl J, de Vos R, Del Tredici K. Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113:421-429.  https://doi.org/10.1007/s00401-007-0193-x
  58. Phillips R, Powley T. Innervation of the gastrointestinal tract: Patterns of aging. Autonomic Neuroscience. 2007;136:1-19.  https://doi.org/10.1016/j.autneu.2007.04.005
  59. Wade P, Hornby P. Age-Related Neurodegenerative Changes and How They Affect the Gut. Science of Aging Knowledge Environment. 2005;2005(12):pe8.  https://doi.org/10.1126/sageke.2005.12.pe8
  60. Wakabayashi K, Takahashi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Advances in Neurology. 1993;60:609-612. 
  61. Andersson K. Mechanisms of Disease: central nervous system involvement in overactive bladder syndrome. Nature Clinical Practice Urology. 2004;1(2):103-108.  https://doi.org/10.1038/ncpuro0021
  62. Petrovitch H, Abbott R, Ross G, et al. Bowel movement frequency in late-life and substantia nigra neuron density at death. Movement Disorders. 2009;24:371-376.  https://doi.org/10.1002/mds.22360
  63. Hinkle J, Perepezko K, Mills K, et al. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord. 2018;55:8-14.  https://doi.org/10.1016/j.parkreldis.2018.08.010
  64. Derkinderen P, Shannon K, Brundin P. Gut feelings about smoking and coffee in Parkinson’s disease. Movement Disorders. 2014;29:976-979.  https://doi.org/10.1002/mds.25882
  65. Houser M, Chang J, Factor S, et al. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson’s Disease. Movement Disorders. 2018;33:793-804.  https://doi.org/10.1002/mds.27326
  66. Brudek T. Inflammatory Bowel Diseases and Parkinson’s Disease. J Parkinsons Dis. 2019;9(s2):331-344.  https://doi.org/10.3233/jpd-191729
  67. Lin J, Lin C, Hsu C, Lin C, Kao C. Association Between Parkinsonʼs Disease and Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22(5):1049-1055. https://doi.org/10.1097/mib.0000000000000735
  68. Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977—2014. Gut. 2018;68(1):18-24.  https://doi.org/10.1136/gutjnl-2017-315666
  69. Klegeris A, Giasson B, Zhang H, et al. Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells. The FASEB Journal. 2006;20:2000-2008. https://doi.org/10.1096/fj.06-6183com
  70. McGeer P, McGeer E. The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp Neurol. 2008;212:235-238.  https://doi.org/10.1016/j.expneurol.2008.04.008
  71. Hunot S, Dugas N, Faucheux B, et al. FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells. The Journal of Neuroscience. 1999;19:3440-3447. https://doi.org/10.1523/jneurosci.19-09-03440.1999
  72. Villarán R, Espinosa-Oliva A, Sarmiento M, et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem. 2010;114(6):1687-1700. https://doi.org/10.1111/j.1471-4159.2010.06879.x
  73. Kellow J, Gill R, Wingate D. Modulation of human upper gastrointestinal motility by rectal distension. Gut. 1987;28:864-868.  https://doi.org/10.1136/gut.28.7.864
  74. Astarloa R, Mena M, Sánchez V, et al. Clinical and Pharmacokinetic Effects of a Diet Rich in Insoluble Fiber on Parkinson Disease. Clin Neuropharmacol. 1992;15:375-380.  https://doi.org/10.1097/00002826-199210000-00004
  75. Ashraf W, Wszolek Z, Pfeiffer R, et al. Anorectal function in fluctuating (on-off) Parkinson’s disease: Evaluation by combined anorectal manometry and electromyography. Movement Disorders. 1995;10(5):650-657.  https://doi.org/10.1002/mds.870100519
  76. Su A, Gandhy R, Barlow C, Triadafilopoulos G. Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson’s disease and chronic constipation. BMJ Open Gastroenterol. 2016;3(1):e000118. https://doi.org/10.1136/bmjgast-2016-000118
  77. Rao S. Dyssynergic Defecation and Biofeedback Therapy. Gastroenterol Clin North Am. 2008;37(3):569-586.  https://doi.org/10.1016/j.gtc.2008.06.011
  78. Mathers S, Kempster P, Law P, et al. Anal Sphincter Dysfunction in Parkinson’s Disease. Arch Neurol. 1989;46:1061-1064. https://doi.org/10.1001/archneur.1989.00520460037010
  79. Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in Parkinson’s disease. J Neural Transm. 2008;115(3):443-460.  https://doi.org/10.1007/s00702-007-0855-9
  80. Del Tredici K, Rüb U, de Vos R, et al. Where Does Parkinson Disease Pathology Begin in the Brain? Journal of Neuropathology & Experimental Neurology. 2002;61(5):413-426.  https://doi.org/10.1093/jnen/61.5.413
  81. Albanese A, Brisinda G, Bentivoglio A, Maria G. Treatment of Outlet Obstruction Constipation in Parkinson’S Disease With Botulinum Neurotoxin A. American Journal of Gastroenterology. 2003;98(6):1439-1440. https://doi.org/10.1111/j.1572-0241.2003.07514.x
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.